arrow
J

Jan Maciej Zaucha

medical university of gdansk
H指数:33
被引数:4,361

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Comparison of Outcomes in Patients with Secondary Acute Promyelocytic Leukemia (APL) and De Novo APL—A Case-Matched Retrospective Analysis of the Polish Adult Leukemia Group (PALG)

比较继发性急性早幼粒细胞白血病(APL)与原发APL患者的结局——波兰成人白血病组(PALG)的病例匹配回顾性分析

Cancers
IF4.4
2026-09-080
OA
Radiation-Free Therapy for the Initial Treatment of Good Prognosis Early Non-Bulky Hodgkin Lymphoma, Defined by a Low Metabolic Tumor Volume and a Negative Interim PET After 2 Chemotherapy Cycles: The RAFTING Trial Protocol

无放射治疗对低代谢肿瘤体积和2个化疗周期后中期PET阴性定义的良好预后早期非巨大肿块霍奇金淋巴瘤初始治疗的RAFTING试验方案

2026-08-290
OA
Glofitamab plus gemcitabine and oxaliplatin for relapsed/refractory DLBCL: 3-year follow-up of STARGLO

戈利妥昔单抗联合吉西他滨和奥沙利铂治疗复发/难治性弥漫大B细胞淋巴瘤:STARGLO研究的3年随访

2026-06-130
OAAI
Daratumumab or active observation for asymptomatic biochemical relapse in patients with multiple myeloma
2026-02-011
PRE
PIM kinase inhibition attenuates pro-tumoral and immunosuppressive functions of macrophages in classic Hodgkin lymphoma

PIM kinase抑制减弱了经典霍奇金淋巴瘤中巨噬细胞的促肿瘤和免疫抑制功能。

2025-12-260
OAAI
Obinutuzumab induction and maintenance in patients with Waldenström macroglobulinaemia: an open-label, single-arm phase 2 study

奥比妥珠单抗诱导和维持治疗华氏巨球蛋白血症患者的疗效:一项开放标签、单臂2期研究

2025-07-250
OA
Pivotal results of SELECT-MDS-1 phase 3 study of tamibarotene with azacitidine in newly diagnosed higher-risk MDS

他米巴罗替与阿扎胞苷联合治疗新诊断高危骨髓增生异常综合征(MDS)的SELECT-MDS-1三期研究的关键结果

2025-05-090
OAAI
Impact of First- and Second-Generation Tyrosine Kinase Inhibitors on the Development of Graft-Versus-Host Disease in Individuals with Chronic Myeloid Leukemia: A Retrospective Analysis on Behalf of the Polish Adult Leukemia Group

第一代和第二代酪氨酸激酶抑制剂对慢性粒细胞白血病患者移植物抗宿主病发展的影响: 代表波兰成人白血病组的回顾性分析

2025-01-110
OAAI
Combining mass spectrometry with quantitative continuous scoring to unlock the full quantitative potential of immunohistochemistry

结合质谱技术与定量连续评分,以释放免疫组织化学的完整定量潜力

2024-09-010
PRE
Health-related quality of life in patients with multiple myeloma treated in the phase 3 ATLAS trial of post-transplant maintenance with carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone
2024-05-141
OA
Effective treatment of Clostridioides difficile infection improves survival and affects graft-versus-host disease: a multicenter study by the Polish Adult Leukemia Group

艰难梭菌感染的有效治疗可提高生存率并影响移植物抗宿主病: 波兰成人白血病小组的一项多中心研究

2024-03-110
OAAI
Identification of novel genetic loci for risk of multiple myeloma by functional annotation
LEUKEMIA
IF13.4
2023-09-182
OAAI
Quantification of HER2 expression and spatial biology using computational pathology: A cross-assay validation study in breast cancer
2023-03-012
PRE